Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer
- PMID: 33095426
- DOI: 10.1007/s43032-020-00335-y
Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer
Abstract
Cervical cancer is the fourth most common female cancer worldwide. Long non-coding RNAs (lncRNAs), such as SOX21-AS1, play pivotal roles in the progression and metastasis of cancer. We previously described that SOX21-AS1 was hypomethylated in cervical cancer (CC) and aimed to further explore the relationship between methylation of the SOX21-AS1 promoter and CC using clinical cervical samples. Pyrosequencing was performed to detect the methylation status of the SOX21-AS1 promoter in 33 cervical specimens. Additionally, expression levels of related genes in 43 clinical cervical specimens were measured using quantitative real-time PCR (qRT-PCR). The SOX21-AS1 promoter was significantly hypomethylated in CC (P < 0.01). SOX21-AS1 hypomethylation was also significantly associated with an advanced Federation of Gynecology and Obstetrics (FIGO) stage (P < 0.01). The expression levels of SOX21-AS1 and SOX21 were noted to be higher in cancer vs. normal cervix (all P < 0.001). Moreover, the expression of SOX21-AS1 was positively correlated with SOX21 in all samples (r = 0.891, P < 0.001). Methylation statue of the SOX21-AS1 promoter region was negatively correlated with the expression levels of SOX21-AS1 and SOX21 (SOX21-AS1, r = - 0.628; SOX21, r = - 0.648; both P < 0.001). The methylation status of SOX21-AS1 displayed promising diagnostic potential for CC, exhibiting good sensitivity (100.0%) and specificity (69.2%), with an area under the curve of 0.846. In addition, bioinformatic analyses identified a potential link between SOX21-AS1 and the Wnt signaling pathway. Furthermore, methylation status of SOX21-AS1 was negatively correlated with β-catenin/c-myc/cyclin D1 mRNA levels (rs = - 0.529, - 0.462 ,and - 0.383, respectively, P < 0.05). Our findings illuminated that lncRNA SOX21-AS1 showed hypomethylation in cervical cancer and SOX21-AS1 could serve as a novel biomarker for CC diagnosis or a potential therapeutic target.
Keywords: Cervical cancer; Diagnosis; Long non-coding RNA; Promoter methylation; SOX21-AS1.
Similar articles
-
Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.J Cell Physiol. 2019 Aug;234(10):17494-17504. doi: 10.1002/jcp.28371. Epub 2019 Mar 25. J Cell Physiol. 2019. PMID: 30912129
-
Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.Life Sci. 2019 Sep 15;233:116708. doi: 10.1016/j.lfs.2019.116708. Epub 2019 Jul 29. Life Sci. 2019. PMID: 31369759
-
Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5611-5620. doi: 10.26355/eurrev_201907_18295. Eur Rev Med Pharmacol Sci. 2019. PMID: 31298313
-
Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.BMC Genomics. 2022 May 7;23(1):352. doi: 10.1186/s12864-022-08578-6. BMC Genomics. 2022. PMID: 35525925 Free PMC article. Review.
-
Long non-coding RNA SOX21-AS1: A potential tumor oncogene in human cancers.Pathol Res Pract. 2023 Sep;249:154774. doi: 10.1016/j.prp.2023.154774. Epub 2023 Aug 19. Pathol Res Pract. 2023. PMID: 37633003 Review.
Cited by
-
SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/β-Catenin Signaling Pathway.Biochem Genet. 2024 Mar 21. doi: 10.1007/s10528-024-10770-0. Online ahead of print. Biochem Genet. 2024. PMID: 38512584
-
SRY-box transcription factor 21 antisense divergent transcript 1: Regulatory roles and clinical significance in neoplastic conditions and Alzheimer's Disease.J Cancer. 2023 Oct 2;14(17):3258-3274. doi: 10.7150/jca.89619. eCollection 2023. J Cancer. 2023. PMID: 37928430 Free PMC article. Review.
-
Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation.Front Mol Biosci. 2022 Dec 2;9:1067406. doi: 10.3389/fmolb.2022.1067406. eCollection 2022. Front Mol Biosci. 2022. PMID: 36533073 Free PMC article. Review.
-
Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.Front Pharmacol. 2022 Nov 30;13:1065701. doi: 10.3389/fphar.2022.1065701. eCollection 2022. Front Pharmacol. 2022. PMID: 36532719 Free PMC article.
-
Magnetic Nanoparticle-Based Electrochemical Sensing Platform Using Ferrocene-Labelled Peptide Nucleic Acid for the Early Diagnosis of Colorectal Cancer.Biosensors (Basel). 2022 Sep 7;12(9):736. doi: 10.3390/bios12090736. Biosensors (Basel). 2022. PMID: 36140121 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - DOI
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. - DOI
-
- Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65. - DOI
-
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9. - DOI
-
- Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97(4):273–82. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
